This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
MOUNTAIN VIEW, Calif.,
April 10, 2013 /PRNewswire/ -- A new educational program,
Excess Weight and Your Health: A Guide to Effective, Healthy Weight Loss, developed by the Obesity Action Coalition (OAC) and the American College of Physicians (ACP), will be released today at Internal Medicine 2013, the annual scientific meeting of the ACP. The booklet and DVD program, funded by an educational grant from VIVUS, Inc. (NASDAQ: VVUS), focuses on encouraging patients to speak with their physicians about obesity and explores the reasons individuals gain excess weight, as well as effective methods for losing weight and keeping it off.
Excess Weight and Your Health program discusses how people can make better food choices and build more physical activity into their lives, while explaining available medical treatments and surgical options for those struggling with excess weight. The program can be viewed online and ordered free of charge by healthcare professionals at
"Obesity is a complex condition and we need tools like this program that help encourage primary care physicians' communication with patients to find the best treatment plans to achieve the benefits of a healthy weight," said
David L. Bronson, MD, FACP, president of ACP.
"Losing weight is often more complicated than just eating less and exercising more," said Joe Nadglowski, OAC president and CEO. "We are proud to partner with ACP, one of the largest physician groups in
the United States, to encourage healthcare providers to be proactive in having conversations with their patients about the health consequences of excess weight and obesity and how they can safely and effectively manage their weight."
Internal Medicine 2013 takes place
April 11-13, 2013 at the Moscone Center in
San Francisco and features more than 6,000 internal medicine physicians, subspecialists, medical students and allied health professionals from around the world.
VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. For more information about the company, please visit
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ending
December 31, 2012, and periodic reports filed with the Securities and Exchange Commission.
SOURCE VIVUS, Inc.